NanoFUSE Biologics

General Information

Company Name

NanoFUSE Biologics

Founded Year

2018

Location (Offices)

Malden, United States +1

Founders / Decision Makers

Number of Employees

Industries

Biotechnology, Manufacturing

Funding Stage

Social Media

NanoFUSE Biologics - Company Profile

NanoFUSE Biologics is a biotechnology and manufacturing startup based in the United States, founded in 2018. The company's slogan emphasizes its focus on regenerative therapeutics, specifically the replacement or regeneration of human bone cells to form normal bone.

NanoFUSE Biologics' flagship products feature the only FDA-cleared bioactive glass that can be combined with demineralized bone matrix (DBM). This unique combination capitalizes on the osteoinductivity of the DBM component alongside the osteopromotivity of the bioactive glass. These properties have been clinically proven for over 30 years. However, NanoFUSE Biologics is the first to leverage bioactive glass in this novel and patented regenerative therapeutic.

As of now, NanoFUSE Biologics' last investment and associated investors are not publicly disclosed.

Taxonomy: Regenerative Therapeutics, Bioactive Glass, Bone Regeneration, Osteoinductivity, Osteopromotivity, FDA-Cleared, Demineralized Bone Matrix, Biologics, Clinical Proven, Innovative Medical Technology